Description
Current Status on CM for Biologics: Development to Clinical
Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.
- The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering AstraZeneca
- Perspectives on the Development of Continuous Manufacturing for Biological Products
Mark Brower, Principal Scientist
Merck
- Novel Technologies to Enable Continuous Manufacturing of Biologics
Govind Rao, PhD, Director, Center for Advanced Sensor Technology
University of Maryland, Baltimore County
Moderator(s):
- Antonio
R. Moreira,
PhD,
Vice Provost, Academic Affairs,
University of Maryland, Baltimore County
Speaker(s):
- Jon
Coffman,
PhD,
Senior Director of Bioprocess Technology and Engineering,
AstraZeneca
- Mark
Brower,
Principal Scientist,
Merck & Co., Inc.
- Govind
Rao,
PhD,
Professor & Director, Center for Advanced Sensor Technology,
University of Maryland, Baltimore County
Ushma Mehta
7/31/20 1:14 pm
Hello, Is Jon Coffman going to share his presentation on "The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein" ? Thank you